{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:00:03Z","timestamp":1780574403601,"version":"3.54.1"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"DOI":"10.1186\/s40794-026-00305-3","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:46:07Z","timestamp":1780566367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Traveling with chronic viral hepatitis"],"prefix":"10.1186","volume":"12","author":[{"given":"Didem","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio Nunes","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurdes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Habibovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan F.","family":"Corovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Elena","family":"Duduveche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gule","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sertac","family":"Kucukkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Khopkar-Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit Kumar","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Sebastian","family":"Gherlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha K.","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjana","family":"Zerja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Daniel","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of ESCMID Study Group for Viral Hepatitis (ESGVH)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio Nunes","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurdes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Habibovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan F.","family":"Corovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Elena","family":"Duduveche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gule","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sertac","family":"Kucukkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Khopkar-Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit Kumar","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Sebastian","family":"Gherlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjana","family":"Zerja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Daniel","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"305_CR1","unstructured":"Global hepatitis. report 2026. Geneva. World Health Organization; 2026."},{"key":"305_CR2","volume-title":"CDC Yellow Book 2026: Health Information for International Travel. Section 4","author":"Centers for Disease Control and Prevention (CDC)","year":"2025","unstructured":"Centers for Disease Control and Prevention (CDC). Travel-Associated Infections and Diseases. CDC Yellow Book 2026: Health Information for International Travel. Section\u00a0 4. Atlanta (GA): CDC; 2025. Apr 23."},{"issue":"4","key":"305_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.18683\/germs.2024.1442","volume":"14","author":"O S\u0103ndulescu","year":"2024","unstructured":"S\u0103ndulescu O, Hasano\u011flu \u0130, Mati\u010di\u010d M. Updates in viral hepatitis in 2024\u2013summary of education, research and leadership activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). Germs. 2024;14(4):320.","journal-title":"Germs"},{"key":"305_CR4","volume-title":"CDC Yellow Book 2026: Health Information for International Travel","author":"Perspectives","year":"2025","unstructured":"Centers for Disease Control and Prevention, Perspectives. Screening asymptomatic travelers. CDC Yellow Book 2026: Health Information for International Travel. Atlanta: CDC; 2025."},{"issue":"2","key":"305_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.18683\/germs.2025.1464","volume":"15","author":"A Skrzat-Klapaczy\u0144ska","year":"2025","unstructured":"Skrzat-Klapaczy\u0144ska A, Antoniak S, Antonyak S, Protopapas K, Papadopoulos A, Maric D, et al. The status of hepatitis C microelimination among people living with HIV in Central and Eastern Europe in 2022-data from Euroguidelines in Central and Eastern Europe Network Group. Germs. 2025;15(2):144.","journal-title":"Germs"},{"issue":"1","key":"305_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jtm.12002","volume":"20","author":"LH Chen","year":"2013","unstructured":"Chen LH, Barnett ED, Wilson ME, MacLeod W, Yanni EA, Ooi W, et al. Hepatitis B screening in US travelers seen at the Boston area travel medicine network. J Travel Med. 2013;20(1):29\u201336.","journal-title":"J Travel Med"},{"issue":"2","key":"305_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mpmed.2013.11.002","volume":"42","author":"AD Yeap","year":"2014","unstructured":"Yeap AD, Cosgrove CA. Liver disease in the traveller. Medicine. 2014;42(2):79\u201383.","journal-title":"Medicine"},{"issue":"7","key":"305_CR8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1478-3231.2008.01816.x","volume":"28","author":"GM Hirschfield","year":"2008","unstructured":"Hirschfield GM, Kumagi T, Heathcote EJ. Preventative hepatology: minimising symptoms and optimising care. Liver Int. 2008;28(7):922\u201334.","journal-title":"Liver Int"},{"issue":"4","key":"305_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2310\/7060.2000.00059","volume":"7","author":"N Piper-Jenks","year":"2000","unstructured":"Piper-Jenks N, Horowitz HW, Schwartz E. Risk of hepatitis E infections to travelers. J Travel Med. 2000;7(4):194.","journal-title":"J Travel Med"},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/0264-410X(90)90213-6","volume":"8","author":"R Steffen","year":"1990","unstructured":"Steffen R. Risks of hepatitis B for travellers. Vaccine. 1990;8:S31\u20132.","journal-title":"Vaccine"},{"issue":"3","key":"305_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jtm.12026","volume":"20","author":"DF Johnson","year":"2013","unstructured":"Johnson DF, Leder K, Torresi J. Hepatitis B and C infection in international travelers. J Travel Med. 2013;20(3):194\u2013202.","journal-title":"J Travel Med"},{"issue":"10","key":"305_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.amjmed.2005.07.019","volume":"118","author":"JS Keystone","year":"2005","unstructured":"Keystone JS. Travel-related hepatitis B: risk factors and prevention using an accelerated vaccination schedule. Am J Med. 2005;118(10):63\u20138.","journal-title":"Am J Med"},{"issue":"1","key":"305_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40794-016-0031-z","volume":"2","author":"K Poovorawan","year":"2016","unstructured":"Poovorawan K, Soonthornworasiri N, Sa-Angchai P, Mansanguan C, Piyaphanee W. Hepatitis B vaccination for international travelers to Asia. Trop Dis Travel Med Vaccines. 2016;2(1):14.","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"1","key":"305_CR14","doi-asserted-by":"publisher","first-page":"taw069","DOI":"10.1093\/jtm\/taw069","volume":"24","author":"AE Heywood","year":"2017","unstructured":"Heywood AE, Nothdurft H, Tessier D, Moodley M, Rombo L, Marano C, et al. Pre-travel advice, attitudes and hepatitis A and B vaccination rates among travellers from seven countries. J Travel Med. 2017;24(1):taw069.","journal-title":"J Travel Med"},{"issue":"1","key":"305_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12939-022-01677-6","volume":"21","author":"C Freeland","year":"2022","unstructured":"Freeland C, Mendola L, Cheng V, Cohen C, Wallace J. The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives. Int J Equity Health. 2022;21(1):77.","journal-title":"Int J Equity Health"},{"key":"305_CR16","doi-asserted-by":"crossref","unstructured":"Halsey E. CDC yellow book 2026: health information for international travel. Oxford University Press; 2025.","DOI":"10.1093\/oso\/9780197788547.001.0001"},{"issue":"4","key":"305_CR17","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"2","key":"305_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico P, Agarwal K, Berg T, Buti M, Janssen HL, Papatheodoridis G, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"issue":"2","key":"305_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406\u201360.","journal-title":"J Hepatol"},{"issue":"3","key":"305_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4254\/wjh.v4.i3.68","volume":"4","author":"E Franco","year":"2012","unstructured":"Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L, Hepatitis A. Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):68.","journal-title":"World J Hepatol"},{"issue":"3","key":"305_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jceh.2021.12.003","volume":"12","author":"JJ Alukal","year":"2022","unstructured":"Alukal JJ, Naqvi HA, Thuluvath PJ. Vaccination in Chronic Liver Disease: An Update. J Clin Exp Hepatol. 2022;12(3):937\u201347.","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"305_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.18683\/germs.2021.1248","volume":"11","author":"AM Bronstein","year":"2021","unstructured":"Bronstein AM, Lukashev AN, Maximova MS, Sacharova TV. The autochthonous cases of acute strongyloidiasis in the Moscow region. Germs. 2021;11(1):116.","journal-title":"Germs"},{"issue":"3","key":"305_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.18683\/germs.2025.1473","volume":"15","author":"O S\u0103ndulescu","year":"2025","unstructured":"S\u0103ndulescu O, Mati\u010di\u010d M, Garcia F, Blom\u00e9 MA, Mondelli MU, Irving W, et al. Evolving Insights into Viral Hepatitis: Advances, Evidence, and Expert Perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH)\u2014Part 2: Hepatitis B, C, and Delta. Germs. 2025;15(3):263\u201373.","journal-title":"Germs"},{"key":"305_CR24","unstructured":"Skrzat-Klapaczy\u0144ska A, Antoniak S, Antonyak S, Protopapas K, Papadopoulos A, Maric D, et al. editors. The status of hepatitis C microelimination among people living with HIV in Central and Eastern Europe in 2022-data from Euroguidelines in Central and Eastern Europe Network Group. 19th European AIDS Conference; 2023."},{"issue":"2","key":"305_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","volume":"79","author":"EASL Clinical Practice","year":"2023","unstructured":"EASL Clinical Practice. Guidelines on hepatitis delta virus. J Hepatol. 2023;79(2):433\u201360.","journal-title":"J Hepatol"},{"issue":"3","key":"305_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3350\/cmh.2018.0108","volume":"25","author":"SK Na","year":"2019","unstructured":"Na SK, Song BC. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C. Clin Mol Hepatol. 2019;25(3):234\u201344.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"305_CR27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","volume":"73","author":"J-M Pawlotsky","year":"2020","unstructured":"Pawlotsky J-M, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G, et al. EASL recommendations on treatment of hepatitis C: final update of the series\u2606. J Hepatol. 2020;73(5):1170\u2013218.","journal-title":"J Hepatol"},{"issue":"1","key":"305_CR28","first-page":"1181","volume":"12","author":"M Joshua","year":"2024","unstructured":"Joshua M, Austin-Asomeji I, Izah S, Raimi M. Environmental factors exacerbating hepatitis transmission: a mini review. J Pharmacol Clin Toxicol. 2024;12(1):1181.","journal-title":"J Pharmacol Clin Toxicol"},{"issue":"3","key":"305_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jceh.2021.12.003","volume":"12","author":"JJ Alukal","year":"2022","unstructured":"Alukal JJ, Naqvi HA, Thuluvath PJ. Vaccination in chronic liver disease: an update. J Clin experimental Hepatol. 2022;12(3):937\u201347.","journal-title":"J Clin experimental Hepatol"},{"key":"305_CR30","doi-asserted-by":"crossref","unstructured":"Nelson NP. Prevention of hepatitis a virus infection in the united states: recommendations of the advisory committee on immunization practices, 2020. MMWR Recommendations Rep. 2020;69.","DOI":"10.15585\/mmwr.rr6905a1"},{"issue":"1","key":"305_CR31","doi-asserted-by":"publisher","first-page":"2506294","DOI":"10.1080\/21645515.2025.2506294","volume":"21","author":"L Chang","year":"2025","unstructured":"Chang L, Li Z, Liu Y, Fei S, Zhao L, Li J, et al. Immunogenicity and safety of hepatitis A vaccine at different vaccination intervals among adults aged 18 years and above: Interim results. Hum Vaccines Immunotherapeutics. 2025;21(1):2506294.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"2","key":"305_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tmaid.2006.04.004","volume":"5","author":"P Van Damme","year":"2007","unstructured":"Van Damme P, Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis. 2007;5(2):79\u201384.","journal-title":"Travel Med Infect Dis"},{"issue":"3","key":"305_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/hep.510270336","volume":"27","author":"EB Keeffe","year":"1998","unstructured":"Keeffe EB, Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology. 1998;27(3):881\u20136.","journal-title":"Hepatology"},{"issue":"4","key":"305_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/cid\/ciad206","volume":"77","author":"G-J Chen","year":"2023","unstructured":"Chen G-J, Sun H-Y, Lin K-Y, Hsieh S-M, Chuang Y-C, Liu W-D, et al. A randomized clinical trial of 1-dose vs accelerated 2-dose schedule for hepatitis A virus (HAV) revaccination among people with human immunodeficiency virus who were nonresponders or had seroreversion after primary HAV vaccination. Clin Infect Dis. 2023;77(4):529\u201336.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"305_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.18683\/germs.2025.1472","volume":"15","author":"O S\u0103ndulescu","year":"2025","unstructured":"S\u0103ndulescu O, Mati\u010di\u010d M, Garcia F, Blom\u00e9 MA, Mondelli MU, Irving W, et al. Evolving Insights into Viral Hepatitis: Advances, Evidence, and Expert Perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH)\u2014Part 1: Hepatitis A, E, and Herpesvirus-Associated Liver Disease. Germs. 2025;15(3):254\u201362.","journal-title":"Germs"},{"key":"305_CR36","doi-asserted-by":"crossref","unstructured":"Nelson NP. Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR Morbidity Mortal Wkly Rep. 2018;67.","DOI":"10.15585\/mmwr.mm6743a5"},{"issue":"5","key":"305_CR37","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1080\/21645515.2016.1274473","volume":"13","author":"P Van Damme","year":"2017","unstructured":"Van Damme P, Leroux-Roels G, Suryakiran P, Folschweiller N, Van Der Meeren O. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Hum vaccines immunotherapeutics. 2017;13(5):972\u201380.","journal-title":"Hum vaccines immunotherapeutics"},{"issue":"7","key":"305_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jvh.13509","volume":"28","author":"S Rodr\u00edguez-Tajes","year":"2021","unstructured":"Rodr\u00edguez-Tajes S, Pocurull A, Lens S, Mari\u00f1o Z, Olivas I, Soy G, et al. Efficacy of an accelerated double\u2010dose hepatitis B vaccine regimen in patients with cirrhosis. J Viral Hepatitis. 2021;28(7):1019\u201324.","journal-title":"J Viral Hepatitis"},{"issue":"4","key":"305_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/jlts.2001.23069","volume":"7","author":"M Arslan","year":"2001","unstructured":"Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl. 2001;7(4):314\u201320.","journal-title":"Liver Transpl"},{"issue":"1","key":"305_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/14760584.2025.2502643","volume":"24","author":"K McKoy","year":"2025","unstructured":"McKoy K, Campbell S, Novy P, Janssen RS. Hepatitis B vaccination with HepB-CpG in people living with HIV: a narrative review. Expert Rev Vaccines. 2025;24(1):365\u201372.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"305_CR41","first-page":"196704","volume":"2013","author":"DA Roni","year":"2013","unstructured":"Roni DA, Pathapati RM, Kumar AS, Nihal L, Sridhar K, Tumkur Rajashekar S. Safety and efficacy of hepatitis B vaccination in cirrhosis of liver. Adv Virol. 2013;2013(1):196704.","journal-title":"Adv Virol"},{"issue":"1","key":"305_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1080\/14760584.2025.2543809","volume":"24","author":"SB Kim","year":"2025","unstructured":"Kim SB, Agampodi S, Saluja T, Sahastrabuddhe S, Kim HS, Kim JH, et al. Hepatitis E vaccine landscape update 2025. Expert Rev Vaccines. 2025;24(1):818\u201333.","journal-title":"Expert Rev Vaccines"},{"issue":"10429","key":"305_CR43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","volume":"403","author":"S Huang","year":"2024","unstructured":"Huang S, Zhang X, Su Y, Zhuang C, Tang Z, Huang X, et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2024;403(10429):813\u201323.","journal-title":"Lancet"},{"issue":"2","key":"305_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cmi.2024.11.016","volume":"31","author":"S Dudman","year":"2025","unstructured":"Dudman S, Zerja A, Hasano\u011flu \u0130, Ruta S, van Welzen B, Nicolini LA, et al. Global vaccination against hepatitis E virus: position paper from the European society of clinical microbiology and infectious diseases viral hepatitis study group. Clin Microbiol Infect. 2025;31(2):201\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"305_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.18683\/germs.2024.1416","volume":"14","author":"V\u0218 Ple\u0219ca","year":"2024","unstructured":"Ple\u0219ca V\u0218, Marinescu AG, Voiosu C, Dr\u0103g\u0103nescu AC, Streinu-Cercel A, Vilaia A, et al. Occurrence of acute otitis and sinusitis in patients hospitalized for influenza. Germs. 2024;14(1):38.","journal-title":"Germs"},{"issue":"9","key":"305_CR46","doi-asserted-by":"publisher","first-page":"e031070","DOI":"10.1136\/bmjopen-2019-031070","volume":"9","author":"S H\u00e4rm\u00e4l\u00e4","year":"2019","unstructured":"H\u00e4rm\u00e4l\u00e4 S, Parisinos CA, Shallcross L, O\u2019Brien A, Hayward A. Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis. BMJ open. 2019;9(9):e031070.","journal-title":"BMJ open"},{"key":"305_CR47","doi-asserted-by":"crossref","unstructured":"Kassianos G, Civljak R, van Essen GA, Falup Pecurariu O, Froes F, Galev A et al. Synthesizing and assessing influenza vaccine evidence: strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the European centre for disease prevention and control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024. Germs. 2024;14(3):301-5.","DOI":"10.18683\/germs.2024.1441"},{"key":"305_CR48","unstructured":"Centers for Disease Control and Prevention. People with certain medical conditions and COVID-19 risk factors. Avaialble at: https:\/\/www.cdc.gov\/covid\/risk-factors\/index.html. Accessed May\u00a004, 2026."},{"issue":"2","key":"305_CR49","doi-asserted-by":"publisher","first-page":"188","DOI":"10.18683\/germs.2023.1384","volume":"13","author":"SD Tarzjani","year":"2023","unstructured":"Tarzjani SD, Kamalzadeh S, Moghadam MT, Ashoobi MT. Clinical challenge of co-infection of SARS-CoV-2 with influenza during the influenza circulation season: Suggestions for prevention. Germs. 2023;13(2):188.","journal-title":"Germs"},{"issue":"7","key":"305_CR50","doi-asserted-by":"publisher","first-page":"100496","DOI":"10.1016\/j.jhepr.2022.100496","volume":"4","author":"S Al-Dury","year":"2022","unstructured":"Al-Dury S, Waern J, Waldenstr\u00f6m J, Alavanja M, Saed HH, T\u00f6rnell A, et al. Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination. JHEP Rep. 2022;4(7):100496.","journal-title":"JHEP Rep"},{"key":"305_CR51","doi-asserted-by":"crossref","unstructured":"Kobayashi M. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged\u2009\u2265\u200950 years: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2024. MMWR Morbidity Mortal Wkly Rep. 2025;74.","DOI":"10.15585\/mmwr.mm7401a1"},{"issue":"1","key":"305_CR52","first-page":"56","volume":"15","author":"MM Meri\u015fescu","year":"2025","unstructured":"Meri\u015fescu MM, Jugulete G, Dijm\u0103rescu I, B\u0103lu\u0163\u0103 AM, Dragomirescu AO. A clinical analysis of the 2024 pertussis outbreak among pediatric patients in an infectious diseases hospital in Bucharest. Romania Germs. 2025;15(1):56.","journal-title":"Romania Germs"},{"key":"305_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.15585\/mmwr.mm7107a1","volume":"71","author":"N Murthy","year":"2022","unstructured":"Murthy N, Wodi AP, Bernstein H, McNally V, Cineas S, Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:229\u201333. https:\/\/doi.org\/10.15585\/mmwr.mm7107a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"305_CR54","doi-asserted-by":"crossref","unstructured":"Zhuang C, Liu X. Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study. 2025;16(1):1699.","DOI":"10.1038\/s41467-025-57021-3"},{"issue":"6","key":"305_CR55","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/HEP.0000000000000671","volume":"79","author":"CJ Karvellas","year":"2024","unstructured":"Karvellas CJ, Bajaj JS, Kamath PS, Napolitano L, O\u2019Leary JG, Sol\u00e0 E, et al. AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis. Hepatology. 2024;79(6):1463\u2013502.","journal-title":"Hepatology"},{"key":"305_CR56","doi-asserted-by":"crossref","unstructured":"Aggeletopoulou I, Davoulou P, Konstantakis C, Thomopoulos K, Triantos C. Response to hepatitis B vaccination in patients with liver cirrhosis. 2017;27(6).","DOI":"10.1002\/rmv.1942"},{"issue":"7","key":"305_CR57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1365-2036.2004.01906.x","volume":"19","author":"G Reiss","year":"2004","unstructured":"Reiss G, Keeffe EB. Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther. 2004;19(7):715\u201327.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"305_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/jhep.2001.25883","volume":"34","author":"MR Arguedas","year":"2001","unstructured":"Arguedas MR, Johnson A, Eloubeidi MA, Fallon MB. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology. 2001;34(1):28\u201331.","journal-title":"Hepatology"},{"issue":"6","key":"305_CR59","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.transproceed.2012.05.071","volume":"44","author":"I Gutierrez Domingo","year":"2012","unstructured":"Gutierrez Domingo I, Pascasio Acevedo JM, Alcalde Vargas A, Ramos Cuadra A, Ferrer R\u00edos MT, Sousa Martin JM, et al. Response to vaccination against hepatitis B virus with a schedule of four 40-\u00b5g doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response. Transpl Proc. 2012;44(6):1499\u2013501.","journal-title":"Transpl Proc"},{"key":"305_CR60","doi-asserted-by":"crossref","unstructured":"Darrat M, Flaherty GT. International travel with a chronic medical illness-health risks, practical challenges and evidence-based recommendations. Int J Travel Med Global Health. 2021;9(2).","DOI":"10.34172\/ijtmgh.2021.09"},{"key":"305_CR61","doi-asserted-by":"crossref","unstructured":"Walker PF. Pre-travel consultation and hepatitis B: a double opportunity for preventing infection in at\u2010risk patients and life\u2010threatening complications in HBV carriers. Oxford University Press Oxford, UK; 2013. pp. 143\u20135.","DOI":"10.1111\/jtm.12027"},{"issue":"2","key":"305_CR62","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0924-8579(02)00290-X","volume":"21","author":"MS Khuroo","year":"2003","unstructured":"Khuroo MS. Viral hepatitis in international travellers: risks and prevention. Int J Antimicrob Agents. 2003;21(2):143\u201352.","journal-title":"Int J Antimicrob Agents"},{"key":"305_CR63","unstructured":"United Nations World Tourism Organization. International Tourism Highlights, 2024 Edition. UNWTO Publications. 2024."},{"issue":"4","key":"305_CR64","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hep Intl. 2019;13(4):353\u201390.","journal-title":"Hep Intl"},{"key":"305_CR65","doi-asserted-by":"crossref","unstructured":"Lee WM, editor Acute liver failure. Seminars in respiratory and critical care medicine. Thieme Medical Publishers; 2012.","DOI":"10.1055\/s-0032-1301733"},{"issue":"10","key":"305_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.amjmed.2005.07.013","volume":"118","author":"EB Keeffe","year":"2005","unstructured":"Keeffe EB. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med. 2005;118(10):21\u20137.","journal-title":"Am J Med"},{"issue":"10","key":"305_CR67","doi-asserted-by":"publisher","first-page":"a031716","DOI":"10.1101\/cshperspect.a031716","volume":"8","author":"KH Jacobsen","year":"2018","unstructured":"Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harbor Perspect Med. 2018;8(10):a031716.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"305_CR68","unstructured":"World Health Organization. Hepatitis A [Internet]. Geneva, World Health Organization. 2025 Feb 12 [cited 2025 Dec 3]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-a"},{"key":"305_CR69","unstructured":"European Centre for Disease Prevention and Control. Rapid risk assessment \u2013 Multi-country outbreak of hepatitis A in the EU\/EEA\u201318 June 2025. Volume ECDC. Stockholm; 2025."},{"issue":"5","key":"305_CR70","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1056\/NEJM199801293380503","volume":"338","author":"S Vento","year":"1998","unstructured":"Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338(5):286\u201390.","journal-title":"N Engl J Med"},{"key":"305_CR71","unstructured":"Keeffe EB. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc. 2006;117:227\u201337. discussion 37\u2009\u2013\u20098."},{"key":"305_CR72","unstructured":"World Health Organization. Hepatitis E. Geneva: WHO; 10 April 2025 Last Access: 18 November 2025. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e"},{"issue":"2","key":"305_CR73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.18683\/germs.2020.1189","volume":"10","author":"MES Zaki","year":"2020","unstructured":"Zaki MES, Alsayed MAL, Abbas HRR, Ahmed DM, El Ashry AY. Prevalence of hepatitis E virus in children with acute hepatitis: one Egyptian center study. Germs. 2020;10(2):88.","journal-title":"Germs"},{"issue":"1","key":"305_CR74","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116\u201338.","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"305_CR75","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/j.1478-3231.2008.01840.x","volume":"28","author":"U Navaneethan","year":"2008","unstructured":"Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008;28(9):1190\u20139.","journal-title":"Liver Int"},{"issue":"2","key":"305_CR76","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12664-024-01589-z","volume":"43","author":"SK Acharya","year":"2024","unstructured":"Acharya SK. Overview of acute liver failure in India. Indian J Gastroenterol. 2024;43(2):296\u2013311.","journal-title":"Indian J Gastroenterol"},{"issue":"1","key":"305_CR77","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12879-022-07050-w","volume":"22","author":"JW Choi","year":"2022","unstructured":"Choi JW, Son HJ, Lee SS, Jeon H, Cho J-K, Kim HJ, et al. Acute hepatitis E virus superinfection increases mortality in patients with cirrhosis. BMC Infect Dis. 2022;22(1):62.","journal-title":"BMC Infect Dis"},{"key":"305_CR78","doi-asserted-by":"crossref","unstructured":"Kamar N, Rostaing L, Izopet J, editors. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy. Seminars in liver disease. Thieme Medical; 2013.","DOI":"10.1055\/s-0033-1338115"},{"issue":"2","key":"305_CR79","doi-asserted-by":"publisher","first-page":"taac013","DOI":"10.1093\/jtm\/taac013","volume":"29","author":"O Balogun","year":"2022","unstructured":"Balogun O, Brown A, Angelo KM, Hochberg NS, Barnett ED, Nicolini LA, et al. Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008\u20132020. J Travel Med. 2022;29(2):taac013.","journal-title":"J Travel Med"},{"issue":"2","key":"305_CR80","doi-asserted-by":"publisher","first-page":"e70004","DOI":"10.1111\/liv.70004","volume":"45","author":"Q Chen","year":"2025","unstructured":"Chen Q, Huang S, Peng J, Wang P, Shi X, Luo R, et al. The Burden of Hepatitis B and C in Asia, 1990\u20132019: An Update Analysis From the Global Burden of Disease Study 2019. Liver Int. 2025;45(2):e70004.","journal-title":"Liver Int"},{"issue":"1","key":"305_CR81","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12879-025-12396-y","volume":"26","author":"J Bai","year":"2025","unstructured":"Bai J, Lv H, Wang L, You S, Liu D, Wang L, et al. Global, regional, and National burden of hepatitis C from 1990 to 2021 and projections until 2030. BMC Infect Dis. 2025;26(1):25.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"305_CR82","doi-asserted-by":"publisher","first-page":"a021576","DOI":"10.1101\/cshperspect.a021576","volume":"5","author":"M Rizzetto","year":"2015","unstructured":"Rizzetto M, Hepatitis D. virus: introduction and epidemiology. Cold Spring Harbor Perspect Med. 2015;5(7):a021576.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"2","key":"305_CR83","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","volume":"79","author":"MR Brunetto","year":"2023","unstructured":"Brunetto MR, Ricco G, Negro F, Wedemeyer H, Yurdaydin C, Asselah T, et al. EASL Clinical Practice Guidelines on hepatitis delta virus. J Hepatol. 2023;79(2):433\u201360.","journal-title":"J Hepatol"},{"key":"305_CR84","unstructured":"World Health Organization (WHO). Hepatitis D fact sheet. WHO Press; 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-d."},{"key":"305_CR85","unstructured":"World Health Organization. Common health risks, required precautions of travelers and their management. International Travel and Health 2011. WHO; 2011."},{"issue":"2","key":"305_CR86","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jhep.2020.10.013","volume":"74","author":"C-Y Dai","year":"2021","unstructured":"Dai C-Y, Chuang W-L, Yu M-L. EASL recommendations on treatment of hepatitis C: Final update of the series-Some issues. J Hepatol. 2021;74(2):473\u20134.","journal-title":"J Hepatol"},{"issue":"6","key":"305_CR87","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1440-1746.2007.05243.x","volume":"23","author":"M Kumar","year":"2008","unstructured":"Kumar M, Sharma BC, Sarin SK. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol. 2008;23(6):883\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"305_CR88","unstructured":"Miles Clinic. How to protect yourself from food poisoning and hepatitis A while travelling [Internet]. 2024 [cited 2025 Dec 3]. Available from: https:\/\/milesclinic.co.uk\/blog\/how-to-protect-yourself-from-food-poisoning-and-hepatitis-a-while-travelling\/"},{"key":"305_CR89","unstructured":"Travel Health Pro, National Travel Health Network and Centre. Food and water hygiene: Prevention of foodborne diseases [Internet]. 2025 [cited 2025 Dec 3]. Available from: https:\/\/travelhealthpro.org.uk\/factsheet\/44\/food-and-water-hygiene"},{"issue":"9","key":"305_CR90","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1136\/gutjnl-2024-332177","volume":"73","author":"E Vo-Quang","year":"2024","unstructured":"Vo-Quang E, Pawlotsky J-M. Unusual\u2019HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment. Gut. 2024;73(9):1570\u201382.","journal-title":"Gut"},{"issue":"1","key":"305_CR91","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/21505594.2020.1865716","volume":"12","author":"YE Raji","year":"2021","unstructured":"Raji YE, Toung OP, Mohd Taib N, Sekawi ZB. A systematic review of the epidemiology of Hepatitis E virus infection in South\u2013Eastern Asia. Virulence. 2021;12(1):114\u201329.","journal-title":"Virulence"},{"issue":"2","key":"305_CR92","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2015.10.048","volume":"150","author":"G-H Lee","year":"2016","unstructured":"Lee G-H, Tan B-H, Teo EC-Y, Lim S-G, Dan Y-Y, Wee A, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016;150(2):355\u20137. e3.","journal-title":"Gastroenterology"},{"issue":"7","key":"305_CR93","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3201\/eid2307.170318","volume":"23","author":"F Abravanel","year":"2017","unstructured":"Abravanel F, Lhomme S, El Costa H, Schvartz B, Peron J-M, Kamar N, et al. Rabbit hepatitis E virus infections in humans, France. Emerg Infect Dis. 2017;23(7):1191.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"305_CR94","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1038\/s41467-025-59345-6","volume":"16","author":"Z Chen","year":"2025","unstructured":"Chen Z, Wang L, Zhang Y, Li G, Yin J, Fan J, et al. Substantial spillover burden of rat hepatitis E virus in humans. Nat Commun. 2025;16(1):4038.","journal-title":"Nat Commun"},{"issue":"7","key":"305_CR95","doi-asserted-by":"publisher","first-page":"taaa132","DOI":"10.1093\/jtm\/taaa132","volume":"27","author":"LAP Nicolini","year":"2020","unstructured":"Nicolini LAP, Stoney RJ, Della Vecchia A, Grobusch M, Gautret P, Angelo KM, et al. Travel-related hepatitis E: a two-decade GeoSentinel analysis. J Travel Med. 2020;27(7):taaa132.","journal-title":"J Travel Med"},{"issue":"5","key":"305_CR96","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.mpmed.2023.02.008","volume":"51","author":"MFG Veloz","year":"2023","unstructured":"Veloz MFG, Agarwal K. Hepatitis A and E and other hepatotropic viruses. Medicine. 2023;51(5):347\u201350.","journal-title":"Medicine"},{"issue":"3","key":"305_CR97","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/pathogens9030154","volume":"9","author":"B Wang","year":"2020","unstructured":"Wang B, Harms D, Yang X-L, Bock C-T. Orthohepevirus C: an expanding species of emerging hepatitis E virus variants. Pathogens. 2020;9(3):154.","journal-title":"Pathogens"},{"key":"305_CR98","unstructured":"World Health Organization. Yellow fever. Geneva, WHO. 20 October 2025. Last Acess:18 November 2025 Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever"},{"key":"305_CR99","unstructured":"Pan American Health Organization (PAHO). Epidemiological alert: Yellow fever in the Americas Region Washington (DC): PAHO\/WHO. 2025. Last Acess:18 November 2025 Available from: https:\/\/www.paho.org\/en\/documents\/epidemiological-alert-yellow-fever-americas-region-31-may-2025"},{"issue":"4","key":"305_CR100","doi-asserted-by":"publisher","first-page":"e2564","DOI":"10.1002\/rmv.2564","volume":"34","author":"V Campana","year":"2024","unstructured":"Campana V, Inizan C, Pommier JD, Menudier LY, Vincent M, Lecuit M, et al. Liver involvement in dengue: A systematic review. Rev Med Virol. 2024;34(4):e2564.","journal-title":"Rev Med Virol"},{"issue":"1","key":"305_CR101","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1186\/s12879-025-11549-3","volume":"25","author":"C Wagle","year":"2025","unstructured":"Wagle C, Ghimire DP, Sah AK, Sah AK, Gupta VP, Uranw S, et al. Elevated liver enzyme (AST and ALT) as biomarkers for severe dengue in Nepalese patients: a cross-sectional study. BMC Infect Dis. 2025;25(1):1118.","journal-title":"BMC Infect Dis"},{"key":"305_CR102","doi-asserted-by":"publisher","first-page":"1062408","DOI":"10.3389\/fphar.2022.1062408","volume":"13","author":"PC Matthews","year":"2022","unstructured":"Matthews PC, Campbell C, S\u0103ndulescu O, Mati\u010di\u010d M, Ruta SM, Rivero-Juarez A, et al. Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain? Front Pharmacol. 2022;13:1062408.","journal-title":"Front Pharmacol"},{"issue":"7961","key":"305_CR103","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-023-05948-2","volume":"617","author":"A Ho","year":"2023","unstructured":"Ho A, Orton R, Tayler R, Asamaphan P, Herder V, Davis C, et al. Adeno-associated virus 2 infection in children with non-A\u2013E hepatitis. Nature. 2023;617(7961):555\u201363.","journal-title":"Nature"},{"issue":"10","key":"305_CR104","first-page":"2140","volume":"30","author":"B Hamelin","year":"2024","unstructured":"Hamelin B, P\u00e9rot P, Pichler I, Haslbauer JD, Hardy D, Hing D, et al. Circovirus hepatitis in immunocompromised patient. Switz Emerg Infect Dis. 2024;30(10):2140.","journal-title":"Switz Emerg Infect Dis"},{"issue":"5","key":"305_CR105","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/v16050713","volume":"16","author":"MJ Ali","year":"2024","unstructured":"Ali MJ, Shah PA, Rehman KU, Kaur S, Holzmayer V, Cloherty GA, et al. Immune-escape mutations are prevalent among patients with a coexistence of HBsAg and anti-HBs in a tertiary liver center in the United States. Viruses. 2024;16(5):713.","journal-title":"Viruses"},{"issue":"6","key":"305_CR106","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3201\/eid2406.171513","volume":"24","author":"F Elfrink","year":"2018","unstructured":"Elfrink F, Overbosch FW, Schinkel J, Koen G, Sonder GJ. Hepatitis E in long-term Travelers from the Netherlands to subtropical and tropical countries, 2008\u20132011. Emerg Infect Dis. 2018;24(6):1055.","journal-title":"Emerg Infect Dis"},{"key":"305_CR107","unstructured":"European Association for the Study of the Liver (EASL). Clinical practice guidelines: Hepatitis B virus infection. Update 2025. J Hepatol. 2025."},{"issue":"20","key":"305_CR108","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.3390\/jcm13206032","volume":"13","author":"N Mihai","year":"2024","unstructured":"Mihai N, Olariu MC, Ganea O-A, Adamescu A-I, Molagic V, Aram\u0103 \u0218S, et al. Risk of hepatitis B virus reactivation in COVID-19 patients receiving immunosuppressive treatment: a prospective study. J Clin Med. 2024;13(20):6032.","journal-title":"J Clin Med"},{"issue":"12","key":"305_CR109","doi-asserted-by":"publisher","first-page":"28126","DOI":"10.3390\/ijms161226087","volume":"16","author":"W-L Tsai","year":"2015","unstructured":"Tsai W-L, Sun W-C, Cheng J-S. Chronic hepatitis B with spontaneous severe acute exacerbation. Int J Mol Sci. 2015;16(12):28126\u201345.","journal-title":"Int J Mol Sci"},{"key":"305_CR110","doi-asserted-by":"crossref","unstructured":"Zacharia GS, Jacob A. Acetaminophen: a liver killer or thriller. Cureus. 2023;15(10).","DOI":"10.7759\/cureus.47071"},{"key":"305_CR111","unstructured":"Council A. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV."},{"issue":"1","key":"305_CR112","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4254\/wjh.v6.i1.17","volume":"6","author":"R Teschke","year":"2014","unstructured":"Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol. 2014;6(1):17.","journal-title":"World J Hepatol"},{"issue":"1","key":"305_CR113","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bj\u00f6rnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363\u201373.","journal-title":"Hepatology"},{"issue":"18","key":"305_CR114","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1001\/jama.296.18.2234","volume":"296","author":"LH Chen","year":"2006","unstructured":"Chen LH, Wilson ME, Schlagenhauf P. Prevention of malaria in long-term travelers. JAMA. 2006;296(18):2234\u201344.","journal-title":"JAMA"},{"issue":"3","key":"305_CR115","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S1665-2681(19)31000-2","volume":"12","author":"FI Lieveld","year":"2013","unstructured":"Lieveld FI, van Vlerken LG, Siersema PD, van Erpecum KJ. Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review. Ann Hepatol. 2013;12(3):380\u201391.","journal-title":"Ann Hepatol"},{"issue":"8","key":"305_CR116","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/gutjnl-2014-307023","volume":"64","author":"P Arends","year":"2015","unstructured":"Arends P, Sonneveld MJ, Zoutendijk R, Carey I, Brown A, Fasano M, et al. Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians. Gut. 2015;64(8):1289\u201395.","journal-title":"Gut"},{"issue":"6","key":"305_CR117","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.cgh.2022.08.021","volume":"21","author":"Y-C Liu","year":"2023","unstructured":"Liu Y-C, Jeng W-J, Peng C-W, Chien R-N, Liaw Y-F. The Role of Off-Therapy Viral Kinetics in the Timing and Severity of Flares in Hepatitis B e Antigen\u2013Negative Patients. Clin Gastroenterol Hepatol. 2023;21(6):1533\u201341. e11.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"305_CR118","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.cgh.2016.07.002","volume":"14","author":"W-J Jeng","year":"2016","unstructured":"Jeng W-J, Chen Y-C, Sheen I-S, Lin C-L, Hu T-H, Chien R-N, et al. Clinical relapse after cessation of tenofovir therapy in hepatitis B e antigen\u2013negative patients. Clin Gastroenterol Hepatol. 2016;14(12):1813\u201320. e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"305_CR119","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/liv.15140","volume":"42","author":"YC Liu","year":"2022","unstructured":"Liu YC, Jeng WJ, Peng CW, Chien RN, Liaw YF. Off-tenofovir hepatitis flares in HBeAg\u2010negative patients occur earlier, more frequent and severe than those off\u2010entecavir therapies. Liver Int. 2022;42(3):551\u201360.","journal-title":"Liver Int"},{"key":"305_CR120","doi-asserted-by":"crossref","unstructured":"Richmond JA, Sheppard-Law S, Mason S, Warner SL. The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals. Patient Prefer Adherence. 2016:2479\u201389.","DOI":"10.2147\/PPA.S117757"},{"issue":"4","key":"305_CR121","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1478-3231.2011.02461.x","volume":"31","author":"P Marcellin","year":"2011","unstructured":"Marcellin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Varastet M, et al. Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver Int. 2011;31(4):516\u201324.","journal-title":"Liver Int"},{"key":"305_CR122","doi-asserted-by":"crossref","unstructured":"Norton BL, Akiyama MJ, Agyemang L, Heo M, Pericot-Valverde I-, Litwin AH, editors. Low adherence achieves high HCV cure rates among people who inject drugs treated with direct-acting antiviral agents. Open forum infectious diseases. Oxford University Press US; 2020.","DOI":"10.1093\/ofid\/ofaa377"},{"key":"305_CR123","unstructured":"Australian recommendations for the management of hepatitis C virus infection: a consensus statement. Australian recommendations for the management of hepatitis C virus infection: a consensus statement. Melbourne. 2022. Available at https:\/\/hepcguidelines.org.au\/wp-content\/uploads\/2023\/02\/hepatitis-C-virus-infection-a-consensus-statement-2022-100223.pdf"},{"issue":"8","key":"305_CR124","doi-asserted-by":"publisher","first-page":"100751","DOI":"10.1016\/j.jhepr.2023.100751","volume":"5","author":"M Jachs","year":"2023","unstructured":"Jachs M, Panzer M, Hartl L, Schwarz M, Balcar L, Camp JV, et al. Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression. JHEP Rep. 2023;5(8):100751.","journal-title":"JHEP Rep"},{"issue":"6","key":"305_CR125","doi-asserted-by":"publisher","first-page":"e14385","DOI":"10.1111\/1475-6773.14385","volume":"59","author":"N Bowden","year":"2024","unstructured":"Bowden N, Figueroa JF, Papanicolas I. Bridging borders: Current trends and future directions in comparative health systems research. Health Serv Res. 2024;59(6):e14385.","journal-title":"Health Serv Res"},{"issue":"10308","key":"305_CR126","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376.","journal-title":"Lancet"},{"issue":"3","key":"305_CR127","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","volume":"62","author":"AIHG Panel","year":"2015","unstructured":"Panel AIHG, Chung RT, Davis GL, Jensen DM, Masur H, Saag MS, et al. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932\u201354.","journal-title":"Hepatology"},{"key":"305_CR128","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/liv.14359","volume":"40","author":"ML Shiffman","year":"2020","unstructured":"Shiffman ML. Approach to the patient with chronic hepatitis B and decompensated cirrhosis. Liver Int. 2020;40:22\u20136.","journal-title":"Liver Int"},{"issue":"7","key":"305_CR129","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.14309\/ajg.0000000000002340","volume":"118","author":"S Alexandra","year":"2023","unstructured":"Alexandra S, Nizar M, Jamil\u00e9 W-F, Saleh A, Wong RJ, Limketkai BN, et al. Acute Liver Failure Guidelines. Am J Gastroenterol. 2023;118(7):1128\u201353.","journal-title":"Am J Gastroenterol"},{"key":"305_CR130","doi-asserted-by":"crossref","unstructured":"Martinello M, Solomon SS, Terrault NA, Dore GJ, Hepatitis C, Lancet. (London, England). 2023;402(10407):1085-96.","DOI":"10.1016\/S0140-6736(23)01320-X"},{"issue":"10381","key":"305_CR131","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF, Hepatitis B. Lancet (London England). 2023;401(10381):1039\u201352.","journal-title":"Lancet (London England)"},{"issue":"17","key":"305_CR132","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1001\/jama.2018.3795","volume":"319","author":"LSY Tang","year":"2018","unstructured":"Tang LSY, Covert E, Wilson E, Kottilil S, Chronic Hepatitis B, Infection. Rev Jama. 2018;319(17):1802\u201313.","journal-title":"Rev Jama"},{"key":"305_CR133","unstructured":"International Society of Travel Medicine. Clinic Directory. Available at: https:\/\/www.istm.org\/clinic-directory. Accessed November 18, 2025."},{"issue":"18","key":"305_CR134","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2023.5997","volume":"329","author":"EB Tapper","year":"2023","unstructured":"Tapper EB, Parikh ND. Diagnosis and management of cirrhosis and its complications: a review. JAMA. 2023;329(18):1589\u2013602.","journal-title":"JAMA"},{"key":"305_CR135","unstructured":"Geneva W. The best practices for injections and related procedures toolkit. March; 2010."},{"issue":"2","key":"305_CR136","doi-asserted-by":"publisher","first-page":"s60","DOI":"10.7861\/clinmedicine.18-2-s60","volume":"18","author":"D Mansour","year":"2018","unstructured":"Mansour D, McPherson S. Management of decompensated cirrhosis. Clin Med. 2018;18(2):s60\u20135.","journal-title":"Clin Med"},{"issue":"11","key":"305_CR137","first-page":"939","volume":"12","author":"MM Ram\u00edrez-Mej\u00eda","year":"2024","unstructured":"Ram\u00edrez-Mej\u00eda MM, Castillo-Casta\u00f1eda SM, Pal SC, Qi X, M\u00e9ndez-S\u00e1nchez N. The multifaceted role of bilirubin in liver disease: a literature review. J Clin Translational Hepatol. 2024;12(11):939.","journal-title":"J Clin Translational Hepatol"},{"issue":"4","key":"305_CR138","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2478\/jtim-2020-0034","volume":"8","author":"L Ridola","year":"2020","unstructured":"Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O. Hepatic encephalopathy: diagnosis and management. J translational Intern Med. 2020;8(4):210\u20139.","journal-title":"J translational Intern Med"},{"issue":"1","key":"305_CR139","first-page":"13","volume":"13","author":"H Fadlallah","year":"2025","unstructured":"Fadlallah H, El Masri D, Bahmad HF, Abou-Kheir W, El Masri J. Update on the Complications and Management of Liver Cirrhosis. Med Sci. 2025;13(1):13.","journal-title":"Med Sci"},{"issue":"1","key":"305_CR140","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12876-024-03494-3","volume":"24","author":"Y Lan","year":"2024","unstructured":"Lan Y, Yu Y, Zhang X, Xu X, Yu X, Tu H, et al. Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis. BMC Gastroenterol. 2024;24(1):408.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"305_CR141","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s43162-025-00451-8","volume":"37","author":"V Ezeamii","year":"2025","unstructured":"Ezeamii V, O Doherty NO, Ayozie CO, Figueroa AS, Okobi OE. Telemedicine and its impact on public health in the United States: a contemporary review. Egypt J Intern Med. 2025;37(1):68.","journal-title":"Egypt J Intern Med"},{"issue":"4","key":"305_CR142","doi-asserted-by":"publisher","first-page":"e0195455","DOI":"10.1371\/journal.pone.0195455","volume":"13","author":"B Han","year":"2018","unstructured":"Han B, Yuan Q, Shi Y, Wei L, Hou J, Shang J, et al. The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China. PLoS ONE. 2018;13(4):e0195455.","journal-title":"PLoS ONE"},{"issue":"3","key":"305_CR143","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/ijerph16030398","volume":"16","author":"TV Le","year":"2019","unstructured":"Le TV, Vu TTM, Mai HT, Nguyen LH, Truong NT, Hoang CL, et al. Social determinants of stigma and discrimination in Vietnamese patients with chronic hepatitis B. Int J Environ Res Public Health. 2019;16(3):398.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"305_CR144","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/MPG.0000000000002814","volume":"71","author":"DH Leung","year":"2020","unstructured":"Leung DH, Squires JE, Jhaveri R, Kerkar N, Lin CH, Mohan P, et al. Hepatitis C in 2020: a North American society for pediatric gastroenterology, hepatology, and nutrition position paper. J Pediatr Gastroenterol Nutr. 2020;71(3):407\u201317.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"305_CR145","first-page":"e70064","volume":"32","author":"F Green","year":"2025","unstructured":"Green F, Simmons R, Leeman D, Desai M, Hibbert M. Global Systematic Review of the Measurement of Stigma Associated With People Living With Hepatitis B or Hepatitis. C Viruses. 2025;32(9):e70064.","journal-title":"C Viruses"},{"issue":"1","key":"305_CR146","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s12889-023-17263-6","volume":"24","author":"M Toumi","year":"2024","unstructured":"Toumi M, Wallace J, Cohen C, Marshall C, Kitchen H, Macey J, et al. Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States. BMC Public Health. 2024;24(1):611.","journal-title":"BMC Public Health"},{"issue":"1","key":"305_CR147","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jvh.13894","volume":"31","author":"RT Natour","year":"2024","unstructured":"Natour RT, Midlej A, Mahajna E, Kopelman Y, Abo-Mouch S, Baker FA. Chronic hepatitis B beyond clinical burden: Psychosocial effects and impact on quality of life. J Viral Hepatitis. 2024;31(1):12\u201320.","journal-title":"J Viral Hepatitis"},{"issue":"1","key":"305_CR148","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1186\/s12889-021-11093-0","volume":"21","author":"C Freeland","year":"2021","unstructured":"Freeland C, Farrell S, Kumar P, Kamischke M, Jackson M, Bodor S, et al. Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study. BMC Public Health. 2021;21(1):1004.","journal-title":"BMC Public Health"},{"issue":"1","key":"305_CR149","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1186\/s12889-024-20131-6","volume":"24","author":"C Masterman","year":"2024","unstructured":"Masterman C, Mendlowitz AB, Capraru C, Campbell K, Eastabrook G, Yudin MH, et al. An evolutionary concept analysis: stigma among women living with hepatitis C. BMC Public Health. 2024;24(1):2660.","journal-title":"BMC Public Health"},{"issue":"8","key":"305_CR150","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1080\/13548506.2021.1944651","volume":"27","author":"D Jin","year":"2022","unstructured":"Jin D, Treloar C, Brener L. Hepatitis B virus related stigma among Chinese living in mainland China: a scoping review. Psychol Health Med. 2022;27(8):1760\u201373.","journal-title":"Psychol Health Med"},{"issue":"10161","key":"305_CR151","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","volume":"392","author":"W-K Seto","year":"2018","unstructured":"Seto W-K, Lo Y-R, Pawlotsky J-M, Yuen M-F. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313\u201324.","journal-title":"Lancet"},{"issue":"9367","key":"305_CR152","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(03)13141-8","volume":"361","author":"AM Spira","year":"2003","unstructured":"Spira AM. Assessment of travellers who return home ill. Lancet. 2003;361(9367):1459\u201369.","journal-title":"Lancet"},{"issue":"6","key":"305_CR153","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1056\/NEJMra1508435","volume":"376","author":"GE Thwaites","year":"2017","unstructured":"Thwaites GE, Day NP. Approach to fever in the returning traveler. N Engl J Med. 2017;376(6):548\u201360.","journal-title":"N Engl J Med"},{"key":"305_CR154","doi-asserted-by":"crossref","unstructured":"Fink D, Wani RS, Johnston V. Fever in the returning traveller. BMJ. 2018;360.","DOI":"10.1136\/bmj.j5773"},{"issue":"1","key":"305_CR155","doi-asserted-by":"publisher","first-page":"80","DOI":"10.18683\/germs.2023.1370","volume":"13","author":"A Jerome","year":"2023","unstructured":"Jerome A, Khanna V, Akagi E, Bhargava A. A rare presentation of infectious mononucleosis: cholestatic hepatitis with hyperbilirubinemia. Germs. 2023;13(1):80.","journal-title":"Germs"},{"issue":"22\u201323","key":"305_CR156","first-page":"400","volume":"119","author":"D Paquet","year":"2022","unstructured":"Paquet D, Jung L, Trawinski H, Wendt S, L\u00fcbbert C. Fever in the returning traveler. Deutsches \u00c4rzteblatt international. 2022;119(22\u201323):400.","journal-title":"Deutsches \u00c4rzteblatt international"},{"issue":"1","key":"305_CR157","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Official J Am Coll Gastroenterology| ACG. 2017;112(1):18\u201335.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"6","key":"305_CR158","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy381","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1\u201394.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"305_CR159","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2021.02.015","volume":"75","author":"L Peters","year":"2021","unstructured":"Peters L, Burkert S, Gr\u00fcner B. Parasites of the liver\u2013epidemiology, diagnosis and clinical management in the European context. J Hepatol. 2021;75(1):202\u201318.","journal-title":"J Hepatol"},{"issue":"2","key":"305_CR160","doi-asserted-by":"publisher","first-page":"106328","DOI":"10.1016\/j.jinf.2024.106328","volume":"90","author":"C Thakker","year":"2025","unstructured":"Thakker C, Warrell C, Barrett J, Booth HL, Chiodini PL, Defres S, et al. UK guidelines for the investigation and management of eosinophilia in returning travellers and migrants. J Infect. 2025;90(2):106328.","journal-title":"J Infect"},{"issue":"5","key":"305_CR161","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.jhep.2022.06.031","volume":"77","author":"LP van Leeuwen","year":"2022","unstructured":"van Leeuwen LP, de Jong W, Doornekamp L, van Gorp EC, Wismans PJ, Goeijenbier M. Exotic viral hepatitis: A review on epidemiology, pathogenesis, and treatment. J Hepatol. 2022;77(5):1431\u201343.","journal-title":"J Hepatol"},{"issue":"4","key":"305_CR162","doi-asserted-by":"publisher","first-page":"322","DOI":"10.18683\/germs.2024.1443","volume":"14","author":"M Vasylyev","year":"2024","unstructured":"Vasylyev M, Lamberink H, Svyst I, Khlypnyach O, Sluzhynska O, Sluzhynska M, et al. The infectious disease burden among war related internally displaced people in the Lviv region of Ukraine. Germs. 2024;14(4):322.","journal-title":"Germs"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-026-00305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-026-00305-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-026-00305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:03:11Z","timestamp":1780570991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40794-026-00305-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":162,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1186\/s40794-026-00305-3","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}